SCHEMBL29659519

SCHEMBL29659519

Clc1nc(NCc2ccco2)c2ncn(C3CCCCO3)c2n1

nearest known ligand 0.64

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ YTHDC1 Q96MU7 1/20 0.64
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ NPC1 O15118 1/20 0.54
▸ RAB9A P51151 1/20 0.54
▸ ADORA3 P0DMS8 5/20 0.51
▸ ADORA2A P29274 4/20 0.51
▸ ADORA1 P30542 4/20 0.51
▸ ADORA2B P29275 1/20 0.51
▸ CYP1A2 P05177 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ FLT3 P36888 2/20 0.46
▸ HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20547190 1.00 YTHDC1 (0.64) YTHDC1SMN1; SMN2NPC1RAB9AADORA3
SCHEMBL18587976 0.97 YTHDC1 (0.59) YTHDC1SMN1; SMN2NPC1RAB9AADORA3
SCHEMBL29664960 0.97 YTHDC1 (0.59) YTHDC1SMN1; SMN2NPC1RAB9AADORA3
SCHEMBL18587833 0.89 YTHDC1 (0.58) YTHDC1SMN1; SMN2NPC1RAB9AADORA3
SCHEMBL30409552 0.89 SMN1; SMN2 (0.54) YTHDC1SMN1; SMN2NPC1RAB9AADORA3
SCHEMBL30410457 0.88 SMN1; SMN2 (0.53) YTHDC1SMN1; SMN2NPC1RAB9AADORA3
SCHEMBL29659534 0.88 YTHDC1 (0.55) YTHDC1SMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL20547188 0.88 YTHDC1 (0.55) YTHDC1SMN1; SMN2NPC1RAB9ACYP1A2
SCHEMBL6820915 0.87 ADORA3 (0.57) SMN1; SMN2ADORA3ADORA2AADORA1ADORA2B
SCHEMBL20547610 0.87 NPC1 (0.52) YTHDC1SMN1; SMN2NPC1RAB9AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3615535-B1 9-(2-OXACYCLOALKYL)-9H-PURINE-2,6-DIAMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF SKIN DISORDERS UNIV PALACKEHO (CZ) 2022-06-15 — — EP disclosed
Send feedback